BioLineRx annual total assets
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
BioLineRx Total Assets Growth & History (BLRX)
BioLineRx's total assets was $40.9M for fiscal 2025.
View full BioLineRx company overviewBioLineRx annual total assets history
| Fiscal year | Period ended | Total assets | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $40.9M | $2.0M | +5.14% |
| 2024 | 2024-12-31 | $38.9M | −$25.0M | −39.14% |
| 2023 | 2023-12-31 | $63.9M | −$12.5M | −16.31% |
| 2022 | 2022-12-31 | $76.4M | −$5.0M | −6.15% |
| 2021 | 2021-12-31 | $81.4M | $34.1M | +72.11% |
| 2020 | 2020-12-31 | $47.3M | −$6.3M | −11.72% |
| 2019 | 2019-12-31 | $53.6M | −$2.7M | −4.74% |
| 2018 | 2018-12-31 | $56.2M | −$4.7M | −7.76% |
| 2017 | 2017-12-31 | $61.0M | $22.0M | +56.57% |
| 2016 | 2016-12-31 | $38.9M | — | — |
BioLineRx quarterly total assets
Q4.16
Q4.17
Q2.18
Q4.18
Q2.19
Q4.19
Q2.20
Q4.20
Q2.21
Q4.21
Q2.22
Q4.22
Q2.23
Q4.23
Q2.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Total assets | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $33.5M | −$9.8M | −22.62% |
| Q1 2026 | 2026-03-31 | $38.8M | −$4.7M | −10.83% |
| Q4 2025 | 2025-12-31 | $40.9M | $2.0M | +5.14% |
| Q3 2025 | 2025-09-30 | $39.8M | — | — |
| Q2 2025 | 2025-06-30 | $43.3M | −$21.3M | −33.02% |
| Q1 2025 | 2025-03-31 | $43.5M | — | — |
| Q4 2024 | 2024-12-31 | $38.9M | −$25.0M | −39.14% |
| Q2 2024 | 2024-06-30 | $64.6M | $5.7M | +9.60% |
| Q4 2023 | 2023-12-31 | $63.9M | −$12.5M | −16.31% |
| Q2 2023 | 2023-06-30 | $58.9M | −$8.9M | −13.12% |
| Q4 2022 | 2022-12-31 | $76.4M | −$5.0M | −6.15% |
| Q2 2022 | 2022-06-30 | $67.8M | −$23.5M | −25.72% |
| Q4 2021 | 2021-12-31 | $81.4M | $34.1M | +72.11% |
| Q2 2021 | 2021-06-30 | $91.3M | $38.3M | +72.35% |
| Q4 2020 | 2020-12-31 | $47.3M | −$6.3M | −11.72% |
| Q2 2020 | 2020-06-30 | $53.0M | −$9.0M | −14.48% |
| Q4 2019 | 2019-12-31 | $53.6M | −$2.7M | −4.74% |
| Q2 2019 | 2019-06-30 | $62.0M | $9.7M | +18.66% |
| Q4 2018 | 2018-12-31 | $56.2M | −$4.7M | −7.76% |
| Q2 2018 | 2018-06-30 | $52.2M | — | — |
| Q4 2017 | 2017-12-31 | $61.0M | $22.0M | +56.57% |
| Q4 2016 | 2016-12-31 | $38.9M | — | — |
BioLineRx total assets trends
Over the last five fiscal years, BioLineRx's total assets decreased from $47.3M to $40.9M, a change of −$6.4M. The latest reported quarter, Q2 2026, shows $33.5M.
About the metric
What total assets mean
Total assets are the resources a company controls at a reporting-period end, including cash, investments, receivables, inventory, property, intangible assets, and other reported assets. The composition of assets differs substantially by industry.
Calculation and source
SEC-reported total assets
TickerStat uses total assets reported in company SEC filings. When a filer provides the equivalent balance-sheet total as liabilities and equity, that reported amount is used because total assets must equal total liabilities plus equity. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review BioLineRx source filings ↗